Advanced Search

Share

English Português

Home Most often read

Hematology, Transfusion and Cell Therapy

Hematology, Transfusion and Cell Therapy

ISSN: 2531-1379

Hematology, Transfusion and Cell Therapy is a quarterly scientific publication of the Associação Brasileira de Hematologia, Hemoterapia e Terapia Celular (ABHH), Associazione Italo-Brasiliana di Ematologia (AIBE), Eurasian Hematology Oncology Group (EHOG), and Sociedade Brasileira de Oncologia Pediátrica (SOBOPE).

Hematology, Transfusion and Cell Therapy publishes original articles, review articles and case reports covering various areas in the field of hematology and hemotherapy. The journal was previously published, until 2016, as Revista Brasileira de Hematologia e Hemoterapia.

ISSN print: 2531-1379
ISSN online: 2531-1387

Published by Elsevier Editora Ltda, Rio de Janeiro, Brazil.

See more

Congresso Brasileiro de Hematologia, Hemoterapia e Terapia Celular. HEMO 2024. List of conference abstracts.

Congresso Brasileiro de Hematologia, Hemoterapia e Terapia Celular. HEMO 2024. List of conference abstracts.

Indexed in:

Scopus, Medline, Directory of Open Access Journals (DOAJ), PubMed Central (PMC), Emerging Sources Citation Index (ESCI), SCImago Journal Rank (SJR), SNIP

See more

Follow us:

Impact factor

The Impact Factor measures the average number of citations received in a particular year by papers published in the journal during the two preceding years.

© Clarivate Analytics, Journal Citation Reports 2025

See more

Impact factor 2024

1.6

Citescore

CiteScore measures average citations received per document published.

See more

Citescore 2024

2.0

SJR

SRJ is a prestige metric based on the idea that not all citations are the same. SJR uses a similar algorithm as the Google page rank; it provides a quantitative and qualitative measure of the journal's impact.

See more

SJR 2024

0.360

SNIP

SNIP measures contextual citation impact by wighting citations based on the total number of citations in a subject field.

See more

SNIP 2024

0.754

View more metrics

Open Access Option

Journal Information

Most often read

Vol. 47. Issue. 3

36123

Severe Relapsed Autoimmune Hemolytic Anemia after Booster with mRNA-1273 COVID-19 vaccine

Flordeluna Z. Mesina

Hematol Transfus Cell Ther. 2024;46:485-8

36123

Full text access

Share

17050

ABO blood group discrepancies in blood donor and patient samples at a tertiary care oncology centre: analysis and serological resolution

Priti Desai, Anisha Navkudkar, Sunil Rajadhyaksha

Hematol Transfus Cell Ther. 2024;46:402-7

17050

Full text access

Share

16491

Immune thrombocytopenia in a patient with essential thrombocythemia after SARS-CoV-2 infection: A case report

Barbora Bacova, Maria Maco, Lucie Geislerova, Ivana Zubata, Tomas Kozak, Jan Novak

Hematol Transfus Cell Ther. 2024;46:469-72

16491

Full text access

Share

9406

Diagnosis and management of acute promyelocytic leukemia: Brazilian consensus guidelines 2024 on behalf of the Brazilian Association of Hematology, Hemotherapy and Cellular Therapy

Lorena Lobo de Figueiredo-Pontes, Luiz Fernando Bazzo Catto, Maria de Lourdes Lopes Ferrari Chauffaille, Katia Borgia Barbosa Pagnano, Maria Isabel Ayrosa Madeira, Elenaide Coutinho Nunes, Nelson Hamerschlak, Marcela Cavalcante de Andrade Silva, ... Eduardo Magalhães Rego

Hematol Transfus Cell Ther. 2024;46:553-69

9406

Full text access

Share

7578

Anti-PF4 antibodies and their relationship with COVID infection

Chieh Yang, Irene Wang, Akshit Chitkara, Jibin Swankutty, Rushin Patel, Samir V Kubba

Hematol Transfus Cell Ther. 2024;46:516-23

7578

Full text access

Share

7413

Sudden painless loss of vision as the initial manifestation of acute myeloid leukemia: a case report

Vishal Mangal, Harshit Khurana, Deepti Mutreja, Navin Kumar Yadav, Phani Kumar Chakilam

Hematol Transfus Cell Ther. 2024;46:465-8

7413

Full text access

Share

7264

ABO discrepancy resolution in two patients with acute myeloid leukemia presenting the transient weak expression of A antigen

Marcos Paulo Miola, Tharsis Cardoso de Oliveira, Andrea Aparecida Garcia Guimarães, Octávio Ricci-Junior, Luiz Carlos de Mattos

Hematol Transfus Cell Ther. 2024;46:85-8

7264

Full text access

Share

6591

Spontaneous remission without treatment of acute myelomonocytic leukemia associated with COVID-19 infection

Rafael Peñuela, Indira Hernandez, Mónica Fernandes-Pineda, Lázaro Cortina, Diana Zapata, Olga Urrego, Juan Herrera, Isabel Saenz, ... Margarita Velazco

Hematol Transfus Cell Ther. 2024;46:506-10

6591

Full text access

Share

6296

Thrombocytopenic thrombotic purpura related to COVID-19 vaccine: apropos of 4 cases

Célia Dos Santos, Santiago Castera, José Fernandez, Julieta Soledad Rosales, Franco Crescitelli, Santiago Boughen, Marcelo Iastrebner, Osvaldo Guerrero, ... Analía Sanchez-Luceros

Hematol Transfus Cell Ther. 2024;46:511-5

6296

Full text access

Share

6219

Clinical outcome and prognosis of patients with acute myeloid leukemia submitted to chemotherapy with 5 years of follow-up

Kaira Mara Cordeiro de Albuquerque, Caroline Brandão Joventino, Lia Correia Moreira, Hermano Alexandre Lima Rocha, Lívia Andrade Gurgel, Deivide de Sousa Oliveira, Carlos Ewerton Maia Rodrigues

Hematol Transfus Cell Ther. 2024;46:8-13

6219

Full text access

Share

5728

Characteristics of the post-surgical decrease in platelet counts in orthopedic surgery patients, observations and insights

George Zacharia, Bartosz Walczyszyn, Kolton Smith, Guillaume Stoffels, Colette Spaccavento, Randy Levine

Hematol Transfus Cell Ther. 2024;46 Supl 5:S3-S7

5728

Full text access

Share

5377

Role of therapeutic plasma exchange as a desensitization therapy in human leukocyte antigen incompatible renal transplant patients: A single-center experience

Mohit Chowdhry, Ayushi Yadav, Vandana Sharma, Soma Agrawal

Hematol Transfus Cell Ther. 2024;46:42-8

5377

Full text access

Share

5350

Management of febrile neutropenia: consensus of the Brazilian Association of Hematology, Blood Transfusion and Cell Therapy - ABHH

Marcio Nucci, Celso Arrais-Rodrigues, Maria Daniela Bergamasco, Marcia Garnica, Ana Beatriz Firmato Gloria, Mariana Guarana, Clarisse Machado, Jessica Ramos, ... Belinda Simões

Hematol Transfus Cell Ther. 2024;46 Supl 6:S346-S361

5350

Full text access

Share

5242

Coincidental or causal? A case report of acquired thrombotic thrombocytopenic purpura following mRNA-1273 Covid-19 vaccination

Erinie M Mekheal, Christopher Millet, Nader Mekheal, Moutaz Ghrewati, Ashesha Mechineni, Michael Maroules

Hematol Transfus Cell Ther. 2024;46:489-93

5242

Full text access

Share

5045

Production of dendritic cell vaccines using different methods with equivalent results: Implications for emerging centers

Adriana da Silva Santos Duarte, Audrey Basso Zangirolami, Irene Santos, Fernanda Soares Niemann, Helen Naemi Honma, Emerson Clayton Amaro, Maurício Wesley Perroud, Fernando Vieira Pericole, ... Sara Teresinha Olalla Saad

Hematol Transfus Cell Ther. 2024;46:30-5

5045

Full text access

Share

4851

Epidemiology of immune thrombocytopenia: study of adult patients at a referral hematology service in Northeastern Brazil

Bruna Sobreira Kubrusly, Elsie Sobreira Kubrusly, Hermano Alexandre Lima Rocha, Antonio Brazil Viana Júnior, Marcela Sobreira Kubrusly, Lucas Loiola Ponte Albuquerque Ribeiro, Rosângela de Albuquerque Ribeiro, Fernando Barroso Duarte

Hematol Transfus Cell Ther. 2024;46 Supl 5:S152-S157

4851

Full text access

Share

4772

Detection of ABL1 deletion without BCR-ABL rearrangement in ETP-ALL

Ahmed Makboul, Walaa T. El-Mahdy, Doaa F. Temerik

Hematol Transfus Cell Ther. 2024;46:462-4

4772

Full text access

Share

4745

All about blinatumomab: the bispecific T cell engager immunotherapy for B cell acute lymphoblastic leukemia

Reza Mirfakhraie, Bentolhoda Kuhestani Dehaghi, Mahmoud Dehghani Ghorbi, Haniyeh Ghaffari-Nazari, Mozhdeh Mohammadian, Maryam Salimi, Maria Tavakoli Ardakani, Sayeh Parkhideh

Hematol Transfus Cell Ther. 2024;46:192-200

4745

Full text access

Share

4640

Direct antiglobulin test in the differential diagnosis of ABO hemolytic disease of the newborn: an important tool with high negative predictive value

Samira Ali Abbas, Carla Luana Dinardo, Cárlei Heckert Godinho, Karen Ziza, Bruno Cruz, Juliana Oliveira Martins, Elyse Moritz, Dante M. Langui, José O. Bordin

Hematol Transfus Cell Ther. 2024;46:450-4

4640

Full text access

Share

4523

Flow cytometry immunophenotyping of healthy platelets and hospitalized patients with suspected platelet dysfunction: Challenges for establishing a cutoff value

Daiane Keller Cecconello, Fabiane Spagnol, Ana Paula Alegretti, Diogo André Pilger, Mariela Granero Farias

Hematol Transfus Cell Ther. 2024;46 Supl 5:S136-S142

4523

Full text access

Share

Publish in

Hematology, Transfusion and Cell Therapy

Hematology, Transfusion and Cell Therapy is a member and subscribes the principles of, the Committee on Publication Ethics (COPE)
www.publicationethics.org.

Idiomas

Hematology, Transfusion and Cell Therapy

Home
All contents
Publish your article
About the journal
- Aims and scope
- Editorial Board
Metrics